The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model

J Autoimmun. 2023 May:137:102957. doi: 10.1016/j.jaut.2022.102957. Epub 2022 Nov 23.

Abstract

The gut-associated lymphoid tissue is a primary activation site for immune responses to infection and immunomodulation. Experimental evidence using animal disease models suggests that specific gut microbes significantly regulate inflammation and immunoregulatory pathways. Furthermore, recent clinical findings indicate that gut microbes' composition, collectively named gut microbiota, is altered under disease state. This review focuses on the functional mechanisms by which gut microbes promote immunomodulatory responses that could be relevant in balancing inflammation associated with autoimmunity in the central nervous system. We also propose therapeutic interventions that target the composition of the gut microbiota as immunomodulatory mechanisms to control neuroinflammation.

Keywords: CNS inflammatory Demyelination; Gut microbiota; Immunomodulation; Microbiome; Microbiota interventions; Neuroinflammation.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases* / metabolism
  • Autoimmunity
  • Central Nervous System
  • Gastrointestinal Microbiome*
  • Immunomodulation
  • Inflammation
  • Multiple Sclerosis*